Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Nesfatin-1 in human and murine cardiomyocytes: synthesis, secretion, and mobilization of GLUT-4.

Endocrinology | 2013

Nesfatin-1, a satiety-inducing peptide identified in hypothalamic regions that regulate energy balance, is an integral regulator of energy homeostasis and a putative glucose-dependent insulin coadjuvant. We investigated its production by human cardiomyocytes and its effects on glucose uptake, in the main cardiac glucose transporter GLUT-4 and in intracellular signaling. Quantitative RT-PCR, Western blots, confocal immunofluorescence microscopy, and ELISA of human and murine cardiomyocytes and/or cardiac tissue showed that cardiomyocytes can synthesize and secrete nesfatin-1. Confocal microscopy of cultured cardiomyocytes after GLUT-4 labeling showed that nesfatin-1 mobilizes this glucose transporter to cell peripherals. The rate of 2-deoxy-D-[(3)H]glucose incorporation demonstrated that nesfatin-1 induces glucose uptake by HL-1 cells and cultured cardiomyocytes. Nesfatin-1 induced dose- and time-dependent increases in the phosphorylation of ERK1/2, AKT, and AS160. In murine and human cardiac tissue, nesfatin-1 levels varied with diet and coronary health. In conclusion, human and murine cardiomyocytes can synthesize and secrete nesfatin-1, which is able to induce glucose uptake and the mobilization of the glucose transporter GLUT-4 in these cells. Nesfatin-1 cardiac levels are regulated by diet and coronary health.

Pubmed ID: 24064358 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Phospho-AS160 (Thr642) Antibody (antibody)

RRID:AB_10545274

This polyclonal targets Phospho-AS160 (Thr642)

View all literature mentions

Phospho-ERK1/ERK2 (Tyr204) Monoclonal Antibody (B.742.5) (antibody)

RRID:AB_10980347

This monoclonal targets Phospho-ERK1/ERK2 (Tyr204)

View all literature mentions

AS160 Antibody (antibody)

RRID:AB_2199376

This polyclonal targets TBC1D4

View all literature mentions

Nesfatin-1 (antibody)

RRID:AB_2313672

This unknown targets

View all literature mentions

Desmin (antibody)

RRID:AB_2335684

This monoclonal targets Desmin purified from human muscle

View all literature mentions

Glucose Transporter GLUT4 antibody (antibody)

RRID:AB_305554

This polyclonal targets Glucose Transporter GLUT4

View all literature mentions

Phospho-Akt (Ser473) Antibody (antibody)

RRID:AB_329825

This polyclonal targets Phospho-Akt (Ser473)

View all literature mentions

Akt Antibody (antibody)

RRID:AB_329827

This polyclonal targets Akt

View all literature mentions

GAPDH Antibody (6C5) (antibody)

RRID:AB_559302

This monoclonal targets GAPDH

View all literature mentions